Method and device for treating the cases of subacute saplingo-oophorite

FIELD: medicine; medical engineering.

SUBSTANCE: method involves applying variable electromagnetic field excited by amplitude-modulated signal having carrier frequency in 100-1000 kHz bandwidth and modulating frequency in 10-8000 kHz bandwidth, and irradiation with low intensity quasi-monochromatic radiation of visible and proximal infrared wavelength bandwidth with small spectrum width. Two action elements are used when performing the treatment. The first one is vaginal action element having inductive transmitter of resonant type emitting electromagnetic oscillations with carrier frequency belonging to 100-1000 kHz bandwidth amplitude-modulated in 10-8000 kHz bandwidth and low intensity quasi-monochromatic radiation of visible and proximal infrared wavelength bandwidth with small spectrum width. The treatment is carried out concurrently and in continuous mode. The device has power supply source, sinusoid signal oscillator and vaginal action element having dielectric casing. The casing encloses inductive transmitter winding. The sinusoid signal oscillator has active oscillator with inductive transmitter winding being concurrently used as inductive element of oscillatory circuit of the active oscillator. Low frequency oscillator is additionally available. Its output is connected to active oscillator circuit via modulator. Control tract has in series connected amplitude detector, DC amplifier and indicating unit. An additional supracutaneous treatment element has active oscillator, inductive transmitter winding concurrently serving as active oscillator inductance element, modulator, which input is connected to low frequency oscillator output and its output is connected to active oscillator circuit. The control tract has in series connected amplitude detector, DC amplifier and indicating unit. M photodiodes are connected in series via timer and acoustic indication element.

EFFECT: enhanced effectiveness of treatment.

5 cl, 4 dwg

 

The invention relates to medicine, namely to gynecology.

In the structure of the inflammatory processes of the reproductive system in women under acute oophoritis occupy a leading place.

Diagnosis of this pathology is based on data from clinical and laboratory studies and sonography. When predicting transition subacute oophoritis in tubo-ovarian festering tumor take into account the probable risk factors of the immune system, anamnesis.

In addition to the known medical methods of treatment of patients with subacute forms of oophoritis, used physical methods of therapy - a gentle and diverse effects on the body [1].

Changing local immunity and nonspecific reactivity, physical methods of treatment have absorbing, soothing, reparative effects, normalize metabolism and neuroendocrine processes in the body.

The closest effect is a method of treating chronic inflammation of the uterus by impact of physical factors described in the patent of Russian Federation №2004268 [2].

By a known method exposure is performed using a constant electric current in the presence of two electrodes - vaginal tip and cutaneous PLA is the pictures from stainless steel.

Vaginal tip is introduced into one of the arches of the vagina, and the plate is placed on the skin corresponding Powszechny area, treatment amperage 30-35 mA.

The disadvantage of this method of treatment is the use of DC, during the procedure, one of the electrodes has a galvanic contact with the mucous membrane of the vagina, which leads to electrolysis. Educated products of electrolysis remain in the patient's body and have a negative effect. With this method physiotherapy completely eliminated the use of drugs.

Currently, for the treatment of diseases in the field of gynecology produced by the industry machine magnetotherapy "Inductor - 2 sue" [3].

In the apparatus as a therapeutic effect is used, the influence of an alternating magnetic field of audio frequency is 5000 Hz.

The device is equipped with vaginal emitter with a dielectric body, which houses a coil inductor.

The disadvantage of this apparatus is the low frequency effects.

It is known that at a frequency of 5000 Hz alternating current induced in biological tissues, is distributed mainly in the vascular and interstitial spaces around the cells, as the cell membrane at a frequency of 5000 Hz are thousands of times more resistance compared to the extracellular fluid [4].

The most favorable is the frequency range 100 kHz - 1000 kHz.

In this case, the capacitance of the membranes did not prevent the penetration of current into the cells and the density of the outside and inside of the cell becomes comparable. The penetration depth of the electromagnetic field in biological tissue at a frequency of 100 kHz is equal to 120 cm at a frequency of 1000 kHz - 39 see With increasing frequency, the penetration depth decreases.

Known apparatus "Inductor - 2 sue" may be accepted as equivalent devices for physiotherapy in the treatment of diseases in the field of gynecology.

The known device comprises a power source, a generator of sinusoidal signal, vaginal item exposure containing dielectric housing, which houses a coil.

The task of the invention is to increase the effectiveness of treatment.

This is achieved in that in the method for the treatment of subacute oophoritis by impact of physical factors, according to the invention the influence exercised by an alternating electromagnetic field formed by amplitude-modulated sinusoidal signal with carrier frequency in the range 100 kHz - 1000 kHz and a modulating frequency in the range 10 Hz to 8000 Hz and exposure to low-intensity monochromatic radiation of visible and near-infrared wavelengths with small width of the spectrum when n is power of two items impact which act simultaneously and continuously, the first element of the impact is vaginal and contains inductive emitter resonant type, the second element of exposure is skin and contains inductive emitter resonant type and the emitter of visible and near infrared wavelength ranges, impact every day after the 5th day of the menstrual cycle, with vaginal element of distortion is introduced into one of the posterolateral codes vaginal and cutaneous element effects are placed in the lower abdomen above the fold with a clearance of not more than 5 mm and slowly move in a circle at a speed of not more than 1 cm/s, the duration of the treatment 25 minutes, at the rate of 7-10 procedures.

This is achieved by a device for therapeutic treatment, which contains a power source, a generator of sinusoidal signal and vaginal item exposure containing dielectric housing, which houses a coil inductive transducer according to the invention, a sinusoidal signal generator is made in the form of the oscillator, and the winding of the inductive emitter is both inductive element of the resonant circuit of the oscillator, the device is further provided with a low-frequency generator whose output by the modulator to connect the eh-schema oscillator, equipped with a path control, the input of which is connected to the oscillator circuit, and which includes series-connected amplitude detector, a DC amplifier and an indicator provided with an additional cutaneous element of influence, which contains the oscillator circuit, the inductive winding of the emitter, which is also the inductive element of the resonant circuit of the oscillator, modulator, whose input is connected to the output of the low-frequency generator, and the output from the oscillator circuit, the path control, the input of which is connected to the oscillator circuit, and which includes series-connected amplitude detector, a DC amplifier and indicator, and M LEDs connected in series, the device has an optional timer, and audio item display.

The invention consists in that in the method for the treatment of subacute oophoritis by impact of physical factors that influence carry out an alternating electromagnetic field, which is formed of the amplitude-modulated signal with carrier frequency in the range 100 kHz - 1000 kHz and a modulating frequency in the range 10 Hz to 8000 Hz, and exposure to low-intensity monochromatic radiation of visible and near-infrared wavelengths with Malaysians spectrum. When exposed to use two elements impact. The first is vaginal item exposure containing inductive emitter resonant type, and which emits electromagnetic waves with a carrier frequency in the frequency range 100 kHz to 1000 kHz and a modulation frequency in the frequency range 10 Hz - 8000 Hz. The second is a skin element exposure containing inductive emitter resonant type, which emits electromagnetic waves with a carrier frequency in the frequency range 100 kHz - 1000 kHz, amplitude-modulated frequency in the frequency range 10 Hz - 8000 Hz and emits low-intensity monochromatic radiation of visible and near infrared wavelength ranges with small spectrum width. The impact takes place simultaneously and continuously.

1 shows a functional diagram of the physiotherapeutic device; figure 2 shows a vaginal item exposure; figure 3 - cutaneous element impact; 4 - inductive emitter cutaneous element effects.

The device includes vaginal item exposure 1 and cutaneous element of exposure to 2, and the low-frequency generator 3 and the power source 4. Vaginal item action contains inductive emitter 5, the winding of which is placed on the rod ferrite core 6. Winding 5 pore the government of the capacitor 7 is connected to the oscillator circuit 8 and is inductive element of the resonant circuit of the oscillator. The frequency of the oscillator is determined by the inductance of the winding 5 and the capacitance value of the capacitor 7. Diagram of the oscillator by means of the modulator 9 is connected to the output of the low-frequency generator 3. Vaginal item exposure contains the path of the control 10, the inlet of which is connected to the oscillator circuit 8 and which contains series-connected amplitude detector 11, a DC amplifier 12 and the indicator 13.

Cutaneous element of exposure 2 includes inductive emitter 14 made in the form of an inductor coil which is placed on a flat dielectric frame. The winding of the radiator 14 through a capacitor 15 is connected to the oscillator circuit 16.

The frequency of oscillator 16 is determined by the inductance of the winding 14 and the capacitance value of the capacitor 15. Diagram of the oscillator 16 by means of the modulator 17 is connected to the output of the low-frequency generator 3. Cutaneous element impact 2 comprises a channel control 18, the inlet of which is connected to the oscillator circuit 16, and which contains series-connected amplitude detector 19, a DC amplifier 20 and the indicator 21. The composition of the skin element of exposure 2 includes M LEDs 22, which are connected in series and connected to the power source 4. Ustoychivosti timer 23 and the audio item display 24.

Structurally, the device is made in the form of three separate functional elements, namely vaginal item exposure 1, cutaneous element impact 2 and the element 25, which contains a power source 4, the low-frequency generator 3, the timer 23 and the audio item display 24. Functional elements 1 and 2 are connected with the element 25 by means of a connecting sheet.

Figure 2 shows a vaginal item impact 1.

The element includes a dielectric housing 26, which has the shape of a tube with a flange. Inside the case comes with a ferrite rod core 27 on which is placed a coil inductive emitter 5. The core 27 is fixed in the housing 26 by means of rubber washers 28 and 29. The housing 26 is closed by the cover knob 30, which is made of dielectric material and has the shape of a Cup with a flange. Inside the cover 30 is fixed Board 31, which includes the circuit elements of the oscillator 8, the capacitor 7, the modulator 9 and tract control 10. The cover has a hole, in which the indicator led 13. Vaginal item exposure via cable 32 is connected with the functional element 25.

Figure 3 shows cutaneous element effects 2.

Cutaneous item action contains a dielectric housing 33, which has an inductive emitter containing a flat dielectric to RCAS 34, hosting the winding 14, the light emitter containing a base 35 and a set of LEDs 22, and the Board 36, which includes a capacitor 15 and the elements of the circuits of the oscillator 16, a modulator 17 tract 18. The frame 34 and the base 35 fixed in the housing with adhesive. In the upper part of the housing 33 has a bore in which is mounted indicator led 21. The housing 33 is closed by a plastic cover 36, which is in the Central part of the transparent window 37. Cover 36 is secured with a plastic nut 38. The top of the casing 33 is closed by a cover 39. Cutaneous element exposure using the cable 40 is connected with the functional element 25.

4 shows an inductive emitter cutaneous element exposure. The emitter includes a flat dielectric frame 34, which is made with a Central hole in the form of radially arranged blades with gap. The winding 14 is in the form of a spiral. Wire each spiral turn around all the petals from coil to coil a wire around one or the other side of each petal frame. The odd number of blades.

The device operates as follows.

Powering the device. The vaginal item impact 1 oscillator 8 generates a high-frequency sinusoidal oscillations with a carrier frequency in the frequency range 100 the Hz - 1000 kHz, modulated by the amplitude of low frequency fluctuations coming from the low-frequency generator 3 to the modulator 9.

The frequency of the modulating oscillations is in the frequency range 10 Hz - 8000 Hz. The device uses a "swing" frequency.

High-frequency sinusoidal amplitude-modulated oscillations are radiated by the coil of the radiator 5, which is the emitter of the resonant type, made in the form of an oscillatory circuit consists of the inductance coil 5 and the capacitor 7.

Electromagnetic waves are radiated into the surrounding space.

When placing vaginal item impacts the vagina electromagnetic fluctuations affect all the surrounding organs.

Simultaneously, the skin element impact 2 the oscillator 16 generates a high-frequency sinusoidal oscillations with a carrier frequency in the frequency range 100 kHz - 1000 kHz, modulated by the amplitude of low frequency fluctuations coming from the low-frequency generator 3 to the modulator 17. The carrier frequency oscillator 8 and 16 differ by 5-10%.

High-frequency sinusoidal amplitude-modulated oscillations are radiated by the coil of the emitter 14, which is also the emitter resonant type and is made in the form of an oscillating circuit formed by the range of complete what ewnetu winding 14 and capacitor 15. At the same time on a comb LEDs served pulsating voltage from the power source. The pulse frequency of 100 Hz.

The LEDs 22 to radiate into the space of low-intensity monochromatic radiation of visible and near infrared wavelength ranges with small width of the spectrum (red with a wavelength of 645-675 nm, infrared with a wavelength of 840-950 nm).

During the procedure the skin element of the impact is above the surface of the patient's body with a clearance of not more than 5 mm and moves in a circle at a speed of not more than 1 cm/s clockwise.

At this time, the emitters of electromagnetic waves of radio wave and optical wavelengths, emitting electromagnetic waves in space, affect biological tissue, blood vessels, blood, etc.

The penetration depth of electromagnetic waves of radio-frequency range is 120 cm for a frequency of 100 kHz and 39 cm for a frequency of 1000 kHz. The penetration depth of electromagnetic waves in the optical range up to 7 see

The combination of one element of the impact of the radiator of electromagnetic waves of radio-frequency range and electromagnetic waves in the optical range, allows to obtain a synergistic effect (total effect greater than the sum of effects of each factor), which contributes to the reduction of treatment time, increase the periods of the and remission.

Effects on biological tissue by electromagnetic fluctuations in the radio wave range of the waves causes increase several times the penetration depth of electromagnetic waves in the optical range of wavelengths.

The vaginal item impacts the intensity of the electromagnetic field at the surface inductive emitter of 0.1-0.15 V/m

The skin element of the impact intensity of the electromagnetic field of the radio wave range of 0.1-0.15 V/m, the power density of the red light (with a wavelength of 660 nm is 1.0-1.5 mW/cm2infrared with a wavelength of 870 nm to 2.0 mW/cm2.

The method of treatment is as follows.

Vaginal item exposure injected into one of the posterolateral vaults of the vagina. Set the time of the procedure and include the power supply apparatus. Cutaneous element exposure is placed over the bottom of the stomach with a clearance of not more than 5 mm and slowly move in a circle clockwise with a speed of no more than 1 cm/s treatment Time 20-25 minutes.

Treatment 7-10 treatments. Procedures carried out daily, starting not earlier than the 5th day of the menstrual cycle.

Treatment of inflammation in a number of medical institutions, Omsk showed that electromagnetic resonance physiotherapy simultaneously electromagnetic oscillations of a radio wave and optical ranges in which n has a positive impact on the clinical treatment of oophoritis, reduces the duration of treatment, reduces the number of complications and avoids undesirable side effects of pharmacological preparations.

Effect of local medical determinants of recovery of damaged structures, has a beneficial effect on the nervous, endocrine and other systems.

Therapeutic effect of electromagnetic waves of different wavelengths is associated primarily with its bio-stimulating effect on the activity of metabolic processes in tissues, resulting in faster recovery of the diseased cells.

Sources of information

1. Malevich SURDS, Rusakevich PS Treatment and rehabilitation of gynecological diseases: Ref. The allowance. - Minsk: The High. SHK. 1994

2. RF patent №2004268, class 5 And 61 N 5/00, 1987, bull. No. 45-46, 1993

3. A comprehensive catalogue "products for the communications industry", a thematic catalogue "Medical equipment", M: ECOS, 1994

4. Information support HH Clinical rheoencephalography. - M.: Medicine, 1983

1. A method for the treatment of subacute oophoritis by impact of physical factors, characterized in that the influence exercised by an alternating electromagnetic field formed by amplitude-modulated sinusoidal signal with carrier frequency in the range of 100-1000 kHz and a modulating frequency in the range 10-8000 Hz and irradiation of the bottom of intensivnym monochromatic radiation of visible and near infrared ranges with a small width of the spectrum using two items impact which act simultaneously and continuously, the first element of the impact is vaginal and contains inductive emitter resonant type, the second element of exposure is skin and contains inductive emitter resonant type and the emitter of visible and near infrared wavelength ranges, impact every day not earlier than the 5th day of the menstrual cycle, with vaginal element of distortion is introduced into one of the posterolateral codes vaginal and cutaneous element effects are placed in the lower abdomen above the belly and slowly move in a circle clockwise with a speed of no more than 1 cm/s, the duration of the treatment 25 min, in the course of 7-10 procedures.

2. Device for therapeutic treatment that contains a power source, a generator of sinusoidal signal and vaginal item exposure containing dielectric housing, which houses a coil inductive emitter, characterized in that the sinusoidal signal generator is made in the form of the oscillator, and the winding of the inductive emitter is both inductive element of the resonant circuit of the oscillator is further provided with a low-frequency generator, the output of which through a modulator connected to the oscillator circuit supplied with tracto the control which contains series-connected amplitude detector, a DC amplifier and an indicator provided with an additional cutaneous element of influence, which contains the oscillator, the winding of the inductive emitter, which is also the inductive element of the oscillator, modulator, whose input is connected to the output of the low-frequency generator, and the output from the oscillator circuit, the path control, which contains series-connected amplitude detector, a DC amplifier and indicator, and M LEDs connected in series, a timer and an element of an audible indication.

3. The device according to claim 2, characterized in that the vaginal item action contains the dielectric housing has a cylindrical shape with a variable cross-section, which houses a coil inductive emitter placed on a ferrite rod core, and the Board, where the circuit of the oscillator, modulator and trust control.

4. The device according to claim 2, characterized in that the cutaneous element exposure includes a housing that has a flat dielectric frame to host winding inductive emitter Board, where the circuit of the oscillator, modulator and path control, and M LEDs mounted on the base is the training and connected in series.

5. The device according to claim 2, characterized in that the cutaneous element effects the winding of the inductive emitter is placed on a flat dielectric frame, which is made with a Central hole in the form of radially arranged blades with a gap, and the winding is made in the form of a spiral, wire each spiral turn around all the petals from coil to coil a wire around one or the other side of each petal frame.



 

Same patents:

FIELD: medicine.

SUBSTANCE: method involves producing ophthalmoscopic tumor image and visually estimating its pigmentation. Digital computer-assisted analysis of tumor image color parameters is carried out by applying Adobe Photoshop software. Digital 0 code is assigned to absolutely black color and digital code of 765 is assigned to absolutely white color. Transpupillary diode laser thermotherapy is started with color code of 153 to 289 beginning from power density of 4.2 W/cm2. Color code being of 290 to 503, the treatment begins with 7.8 W/cm2. Color code being of 504 to 635, the treatment begins with 11.4 W/cm2.

EFFECT: enhanced effectiveness of treatment owing to initial power density being accurately selected.

FIELD: medical engineering.

SUBSTANCE: device is applied for carrying out combined simultaneous blood irradiation at red light wavelength and infusion therapy with physiologic saline containing drugs supplied to the same point in patient vein via dropper. Needle of cocoon cross-section is used.

EFFECT: enhanced effectiveness of treatment.

2 cl, 2 dwg

FIELD: medical engineering.

SUBSTANCE: device has monochrome pulsating radiation source, at least two uprights and at least two fans. Gas discharge lamp is used as radiation source. Five gas discharge lamps are arranged in arrow on each upright inclinable at various angles. Each lamp has focusing optical system and filter absorbing ultraviolet radiation and produces pulsating radiation flow with pulse succession frequency 9.4-9.5 Hz and radiation power of at least 400 W. The lamp at the upright top is filled with Mg vapor, the lowest one is filled with Zn vapor only. Three lamps in the middle part are filled with a mixture of Mg and Zn, in Mg and Zn vapor proportion being equal to 3:1, 1:1, 1:3 in moving from upright top to down, respectively.

EFFECT: enhanced effectiveness of treatment.

2 dwg

FIELD: medicine.

SUBSTANCE: method involves administering laser radiation therapy once a day using low intensity pulsating radiation of wavelength equal to 890nmand power density of 0.03 mW/cm2. Injured organ projection to frontal abdominal wall is exposed to radiation at the first laser therapy stage in two fields acting upon each field for 2 min with radiation pulse succession frequency equal to 80 Hz in applying stable contact-type method. Total treatment dose on two fields is equal to 0.008 J/cm2. The second laser therapy stage begins immediately after having finished the first one in applying radiation along the large intestine path using labile contact-type method in a way that radiation pulse succession frequency equal to 80 Hz is applied first during 1 min and then frequencies of 600, 150 and 300 Hz are applied also during 1 min, respectively. Total treatment dose is equal to 0.032 J/cm2 at the second stage. Total treatment dose is equal to 0.04 J/cm2 at both stages.

EFFECT: enhanced effectiveness in inhibiting dysbacteriosis; reduced frequency of postoperative complications.

FIELD: medical engineering.

SUBSTANCE: device has monochrome radiation source designed as photodiode matrix of blue color tightly sealed in light impermeable partition of hollow casing of douche head. The douche head is screened with perforated cover. Cavity is formed between the cover and partition for supplying water. Each photodiode is mounted in front of holes in the cover. The perforated cover has wavy external surface. Autonomous low voltage power supply source is connected to radiation source via commutation device having switch and is enclosed in casing.

EFFECT: enhanced effectiveness of treatment; improved blood supply; reduced blood viscosity.

3 cl, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves exposing cells containing virus to radiation. Pulsating monochromatic light with pulses succession frequency being equal to 9.4 Hz is applied with wavelength group of 516.7, 517.2, 518.2 nm and then with 636.2 nm of total power not less than 400W. Power ratios in wavelength group is first equal to 1:0 then 1:1,1:3, 3:1, 0:1. Exposure time is equal to at the level of 20 min.

EFFECT: enhanced effectiveness of treatment.

2cl,1 tbl

FIELD: medicine, applicable for stopping of pains of various nature.

SUBSTANCE: the device has a quantum-mechanical oscillator located in a casing, magnet, vessel for medicinal agent and a hollow cylinder. The magnet is installed between the oscillator and the vessel. Positioned in the vessel is a hollow cylinder having through holes on its surface.

EFFECT: quick and absolute anestesia.

2 ex, 1 dwg

FIELD: medicine.

SUBSTANCE: method involves filling vitreous cavity with perfluororganic compound. Two electrodes manufactured from platinum group metal are intravitreally, transretinally introduced into intraocular neoplasm. Electrochemical destruction is carried out with current intensity of 10-100 mA during 1-10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at a dose of 30-120 J/cm2 in perfluororganic compound medium. The transformed retina and tumor destruction products are intravitreally removed with perfluororganic compound volume being compensated with its additional introduction. Boundary-making endolasercoagulation of retinotomy area is carried out. The perfluororganic compound is substituted with silicon oil. The operation is ended in placing sutures over sclerotmy areas and over conjunctiva. Perfluormetylcyclohexylperidin, perfluortributylamine or perfluorpolyester or like are used as the perfluororganic compound for filling vitreous cavity. Platinum, iridium or rhodium are used as the platinum group metals.

EFFECT: complete destruction of neoplasm; reduced dissemination risk.

6 cl, 12 dwg

FIELD: medicine.

SUBSTANCE: method involves building tunnel to posterior eyeball pole in inferoexterior and superexterior quadrants. The tunnel is used for implanting flexible polymer magnetolaser implant to the place, the subretinal neovascular membrane is localized. The implant has a permanent magnet shaped as a cut ring and is provided with drug delivery system and a short focus scattering lens of laser radiator connected to light guide. The permanent implant magnet is axially magnetized and produces permanent magnetic field of 5-7 mTesla units intensity. It is arranged with its north pole turned towards sclera at the place of the subretinal neovascular membrane projection with extrascleral arrangement of laser radiator lens membrane being provided in the subretinal neovascular membrane projection area. The other implant end is sutured to sclera 5-6 mm far from the limb via holes made in advance. The implant is covered with conjunctiva and retention sutures are placed thereon. Light guide and drug supply system lead is attached to temple with any known method applied. Drugs are supplied via the implant drug supply system in retrobulbary way in any order. Triombrast is given in the amount of 0,4-0,6 ml and dexamethasone or dexone in the amount of 0,4-0,6 ml during 3-4 days every 12 h. 0.1-1% aqueous solution of khlorin is intravenously introduced at the third-fourth day after setting the implant as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, at a bolus dose of 0.8-1.1 mg/kg. Visual control of subretinal neovascular membrane cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the subretinal neovascular membrane with the photosensitizer to maximum saturation level, intravitreous, transretinal laser radiation of 661-666 nm large wavelength is applied at general dose of 30-120 J/cm2. The flexible polymer magnetolaser implant is removed and sutures are placed on conjunctiva. Permanent magnet of the flexible polymer magnetolaser implant is manufactured from samarium-cobalt, samarium-iron-nitrogen or neodymium-iron-boron system material. The photosensitizer is repeatedly intravenously introduced at the same dose in 2-3 days after the first laser radiation treatment. Visual intraocular neoplasm cells fluorescence control is carried out using fluorescent diagnosis techniques. Maximum level of saturation with the photosensitizer being achieved in the subretinal neovascular membrane via laser light guide and implant lens, repeated laser irradiation of the subretinal neovascular membrane is carried out with radiation dose of 30-60 J/cm2.

EFFECT: accelerated subretinal edema and hemorrhages resorption; regression and obliteration of the subretinal neovascular membrane; prolonged vision function stabilization.

6 cl

FIELD: medicine.

SUBSTANCE: method involves intravitreously introducing two electrodes into intraocular neoplasm after carrying out vitrectomy and retinotomy to expose the intraocular neoplasm. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with current intensity of 100 mA during 1-10 min or 10 mA during 10 min in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2.The transformed retina and tumor destruction products are intravitreally removed. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. Another embodiment of the invention involves adjusting position and size of the intraocular neoplasm in trans-scleral diaphanoscopic way. Rectangular scleral pocket is built above the intraocular neoplasm to 2/3 of sclera thickness with its base turned away from limb. Several electrodes are introduced into intraocular neoplasm structure via the built bed. The electrodes are manufactured from platinum group metal. Electrochemical destruction is carried out with the same current intensity in changing electrodes polarity and their position in the intraocular neoplasm space, and the electrodes are removed. Superficial scleral flat is returned to its place and fixed with interrupted sutures. 0.1-1% aqueous solution of khlorin as photosensitizer, selected from group containing photolon, radachlorine or photoditazine, is intravenously introduced at a dose of 0.8-1.1 mg/kg after having carried out vitrectomy and retinotomy. Visual control of intraocular neoplasm cells fluorescence is carried out by applying fluorescent diagnosis methods. After saturating the intraocular neoplasm with the photosensitizer to maximum saturation level, intravitreous laser radiation is carried out in parallel light beam of wavelength equal to 661-666 nm is applied at a dose of 30-120 J/cm2. The transformed retina and tumor destruction products are intravitreally removed using vitreotome. Boundary-making endolasercoagulation of retinotomy area is carried out after having smoothed and compressed retina with perfluororganic compound. The operation is finished with placing sutures on sclerotomy and conjunctiva. Platinum, iridium or rhodium are used as the platinum group metals. The number of electrodes is equal to 4-8.

EFFECT: reduced risk of metastasizing.

4 cl, 13 dwg

FIELD: medicine.

SUBSTANCE: method involves treating organism with rotating magnetic field. Action mode I has magnetic field intensity of 1.7-3.4 mTesla units giving comfortable organism state. Mode II has magnetic field intensity of 2.9-5.8 mTesla units. Mode III has magnetic field intensity of 0.6-2.3 mTesla units giving discomfort organism state. The treatment is spread over the whole organism by applying modes I-III in any succession order with mode I selected at the beginning and end. Exposure time is equal to 5-10 min in each mode depending on initial organism state. The number of sessions is selected from 3 to 20 in manner individual for each organism.

EFFECT: enhanced effectiveness of treatment.

3 dwg, 1 tbl

FIELD: medical engineering.

SUBSTANCE: device has three concentric inductance coils arranged in mutually perpendicular relation to each other, control unit producing signals for controlling feeding voltage of winding of each inductance coil. The control unit has PC with software installed and interface unit and three-channeled power amplifier. The PC is connected to the power amplifier for controlling voltage on each coil. The power amplifier is used for supplying voltage to coil windings. Coil windings are arranged turn-by-turn in a way that turns of the same number intersect.

EFFECT: enhanced effectiveness of treatment.

5 dwg

FIELD: medicine; medical engineering.

SUBSTANCE: method involves acting upon pathological cells and tissues with constant and/or low frequency alternating electromagnetic field of 1 to 100 mTesla units large intensity and frequency of 1 to 1000 Hz. The device has means for producing constant and/or low frequency alternating electromagnetic fields permeating working space.

EFFECT: enhanced effectiveness in treating pathological tissues without harmfully influencing healthy cells.

19 cl, 5 dwg, 5 tbl

The invention relates to medical equipment and can be used for the treatment of various etiologies methods magnetotherapy

The invention relates to medical engineering, in particular to a device for physiotherapeutic exposure to optical radiation and magnetic field on biological object

The invention relates to medicine and can be used in magnetic therapy

The invention relates to medicine, more specifically to the means of treatment, and can be used in physiotherapy

The invention relates to medical equipment, namely, devices for physiotherapy

FIELD: medicine; medical engineering.

SUBSTANCE: method involves acting upon pathological cells and tissues with constant and/or low frequency alternating electromagnetic field of 1 to 100 mTesla units large intensity and frequency of 1 to 1000 Hz. The device has means for producing constant and/or low frequency alternating electromagnetic fields permeating working space.

EFFECT: enhanced effectiveness in treating pathological tissues without harmfully influencing healthy cells.

19 cl, 5 dwg, 5 tbl

Up!